STM2457 Inhibits Breast Cancer Tumorigenesis via the Inhibition of METTL3
Open Access
- 30 September 2023
- journal article
- research article
- Published by Drug Targets and Therapeutics (DTT) - Pharmaceutical Society of Korea in Drug Targets and Therapeutics
- Vol. 2 (2) , 80-87
Abstract
Pratikshya Shrestha, Hyelim Kang, Ah-yeong Song, Sun-young Jo, Poshan Yugal Bhattarai, Hong Seok Choi. DTT 2023;2:80-7. https://doi.org/10.58502/DTT.23.0015Keywords
This publication has 33 references indexed in Scilit:
- Translation initiation factors and their relevance in cancerCurrent Opinion in Genetics & Development, 2017
- Breast cancerThe Lancet, 2017
- Structural Basis for Cooperative Function of Mettl3 and Mettl14 MethyltransferasesMolecular Cell, 2016
- Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferaseCell Research, 2014
- Regulation of the mRNA half-life in breast cancerWorld Journal of Clinical Oncology, 2014
- A METTL3–METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylationNature Chemical Biology, 2013
- Heterogeneity in breast cancerJournal of Clinical Investigation, 2011
- MCF-7 breast carcinoma cells do not express caspase-3Breast Cancer Research and Treatment, 2008
- Classification of Breast Cancer Cells on the Basis of a Functional Assay for Estrogen ReceptorMolecular Medicine, 1998
- 5-Azacytidine: Mechanism of action and biological effects in mammalian cellsPharmacology & Therapeutics. Part A: Chemotherapy, Toxicology and Metabolic Inhibitors, 1978